GSK-8853

N/A

Report date: 2025/03/21 08:53:14
NME

Base Information

Drug NameGSK-8853
Drug Alias NameGSK-8853
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 4B inhibitors
TargetsNonstructural protein 4B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A